DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Ajooni Biotech Limited — Outcome of Board Meeting

NSE 2 hrs ago·14 Aug 2026, 10:20 am

Ajooni Biotech

Ajooni Biotech Limited has informed stock exchanges that its board has approved the financial results for the period ending June 30, 2026. This regulatory filing confirms the company has completed the internal review and documentation process for this reporting cycle.

For investors, this development is a procedural milestone. It signals that the company is in the final stages of closing its books for the quarter, paving the way for the formal release of earnings data to the market.

Investors should watch for the official release of the financial statements. The detailed figures, including revenue and profit margins, will provide the most relevant insight into the company's current performance and future outlook.